Received Mar 10, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
Fever; aches; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On 26-FEB-2026, the patient received the 1st dose of Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced fever (Verbatim: Fever) and pain (Verbatim: aches). The outcome of the fever and pain were not reported. It was unknown if the reporter considered the fever and pain to be related to Shingles vaccine. It was unknown if the company considered the fever and pain to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 02-MAR-2026 This case was reported by patient via interactive digital media. Patient stated that had the first one on Thursday and had fever, aches, was thinking of not getting the second dose. The batch number was not provided, and we are unable to contact the reporter.